Contractor profile

Modernatx, Inc.

FY2022 · complete year · data as of 2026-07-11

No FY2026 activity recorded for this recipient. Showing FY2022, its most recent year with data.

prime recipient of federal awards · UEI WJYNZ8AK2D47 Source
$331.3M
Obligated
FY2022
2
Funding agencies
82%
From Health and Hum…
18%
Non-competed
1
States
100%
In Massachusetts
3
Industries

In FY2022, Modernatx, Inc. received $331.3M in federal awards from 2 agencies, 82% of it from the Department of Health and Human Services, with 100% of the work performed in Massachusetts. Across FY2020 to FY2022 its recorded total is $9.9B. Computed

Where this money comes from

Source
FUNDING AGENCIES
MODERNATX, INC.
HHS
$0.3B
1 other agencies
$0.1B
Modernatx, Inc.
$0.3B
FY2022 obligated
band width = obligations · FY2022 · source: USASpending.gov

Where the work lands

Source
Massachusetts$331.3M

Key takeaways

Computed
FY2022 · complete year · data as of 2026-07-11
  • Modernatx, Inc. received $331.3M in federal obligations in FY2022, down 95% from $7.4B in FY2021.
  • The Department of Health and Human Services accounted for 82% of it.
  • Of its $331.3M in contract obligations, 18% was non-competed, based on FPDS extent-competed codes.
  • Its largest recorded industry was Biological Product (except Diagnostic) Manufacturing, at $308.5M.

Obligations by year

Computed
$2.2B
FY20
$7.4B
FY21
$331.3M
FY22
▼ 85%
since FY20

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2022, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
100M SARS-COV-2 MRNA-1273 Vaccine DosesW911QY20C0100Department of Defense$8.2B2020-08-112023-08-10Massachusetts
Moderna Therapeutics, Inc:advance the Development of an Mrna Vaccine for the Prevention…HHSO100201600029CDepartment of Health and Human Services$73M2016-09-012024-07-01Massachusetts

Largest FY2022 awards

Awards that started in FY2022, by the amount obligated on each so far.

No award on record started in FY2022.

What it does (NAICS / PSC)

Biological Product (except Diagnostic) Manufacturing$308.5M
Pharmaceutical Preparation Manufacturing$59M

Competition

18%non-competed (often called no-bid), of $331.3M in contract obligations in FY2022Computed

This describes how contracts were awarded, not wrongdoing.

Corporate family

Reported divisions

Inferred
Moderna US, Inc.$1.8B

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.